| 000 | 01560 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513183157.0 | ||
| 264 | 0 | _c19990802 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/s0306-4522(98)00628-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatthies, H | |
| 245 | 0 | 0 |
_aGlycosylation of proteins during a critical time window is necessary for the maintenance of long-term potentiation in the hippocampal CA1 region. _h[electronic resource] |
| 260 |
_bNeuroscience _c1999 |
||
| 300 |
_a175-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBrefeldin A _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
| 650 | 0 | 4 |
_aFucose _xmetabolism |
| 650 | 0 | 4 | _aGlycosylation |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLong-Term Potentiation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSwainsonine _xpharmacology |
| 650 | 0 | 4 |
_aTunicamycin _xpharmacology |
| 700 | 1 | _aKretlow, J | |
| 700 | 1 | _aMatthies, H | |
| 700 | 1 | _aSmalla, K H | |
| 700 | 1 | _aStaak, S | |
| 700 | 1 | _aKrug, M | |
| 773 | 0 |
_tNeuroscience _gvol. 91 _gno. 1 _gp. 175-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(98)00628-9 _zAvailable from publisher's website |
| 999 |
_c10294878 _d10294878 |
||